cannatrek

Company in the news

iX Biopharma inks supply agreement with Cannatrek to supply medicinal cannabis wafer in Australia

The agreement marks iX Biopharma’s official entry into the high-growth Australian cannabis market, which is expected to grow from US$0.04 billion in 2020 to US$1.23 billion in 2024.
×